LL-37 peptide and skin conditions: what the science actually supports

What did @taylorreidcoachin actually say?

The creator describes LL-37 as "an antifungal peptide" and claims it helps with "acne, hives, eczema, and rosacea." She ties her own acne to progesterone use and says LL-37 has been "clearing out" her breakouts. These are personal anecdotes framed as general skincare advice, and that distinction matters a lot before anyone runs to source this peptide.

To be fair, she's not claiming a cure. She's sharing personal experience and recommending a peptide for skin issues. But 13,500 viewers aren't all going to parse that nuance, and the caption's language, calling it a "game-changer" for acne, rosacea, eczema, and hives, goes considerably further than the transcript does. The gap between what she said and what the caption promises is worth noting.

Does the science back this up?

Partially, but the evidence is nowhere near strong enough to match the caption's confidence. LL-37 is a real human antimicrobial peptide, part of the cathelicidin family, and researchers have studied it seriously. The problem is that the science is complicated and points in multiple directions.

LL-37 does have demonstrated antimicrobial and antifungal activity in vitro. A 2010 paper by Zaiou in the Journal of Molecular Medicine documented cathelicidin activity against bacteria and fungi. For acne specifically, Propionibacterium acnes (now Cutibacterium acnes) has shown susceptibility to LL-37 in laboratory settings (Harder and Schroder, 2002, Journal of Investigative Dermatology).

Here is where it gets genuinely complicated: LL-37 is not just an antimicrobial agent. It also acts as an immune modulator, and in rosacea patients, LL-37 levels are actually elevated, not deficient. A landmark 2007 study by Yamasaki et al. in Nature Medicine found that rosacea skin overproduces LL-37, and that this overexpression drives inflammation. Recommending LL-37 supplementation for rosacea, as the caption does, contradicts this finding fairly directly.

What did they get wrong (or right)?

The antifungal label is partially accurate but incomplete. LL-37 is more precisely described as a broad-spectrum antimicrobial peptide with antifungal properties among several others. Calling it primarily antifungal undersells and mischaracterizes its mechanism.

The acne claim has at least some biological plausibility. LL-37's antimicrobial activity against acne-causing bacteria is documented in cell studies. Whether topical or systemic LL-37 administration translates that activity into clinical acne improvement in humans is a different question, and there are no published randomized controlled trials answering it.

The rosacea claim is the most problematic. Citing LL-37 as helpful for rosacea runs directly counter to Yamasaki et al.'s 2007 findings, which identified elevated cathelicidin LL-37 as a driver of rosacea inflammation rather than a solution to it. This is not a minor quibble. It's a fundamental mischaracterization of the published literature on that specific condition.

The progesterone-acne connection she mentions is real and documented. Hormonal fluctuations, including from progesterone, do affect sebum production and acne. That part checks out.

What should you actually know?

LL-37 is a research-stage compound for cosmetic or therapeutic skin use. There are no FDA-approved topical or injectable LL-37 products for skin conditions, and no human clinical trials have established safe dosing protocols, effective delivery methods, or confirmed outcomes for acne or any of the other conditions named in this video's caption.

Beyond the evidence gap, LL-37 is immunologically active in ways that are not fully characterized in healthy skin. It can stimulate inflammatory pathways as readily as it suppresses them, depending on context. Someone with an already-dysregulated immune response in their skin, which describes most rosacea and eczema patients, could plausibly see a worsening of symptoms. That is not fearmongering. That is what the biology suggests.

If you are dealing with acne, rosacea, eczema, or hives, there are interventions with actual clinical trial data behind them. A dermatologist or a regulated telehealth provider can walk through what fits your specific case. Self-sourcing unregulated peptides based on TikTok anecdotes is a meaningful risk, both in terms of product purity and unpredictable physiological effects.